stockrow
Saturday 7 November 2026
Export STRW’s income statement to Excel — free account
Strawberry Fields REIT, Inc.
STRW Real Estate Reit Healthcare Facilities
Strawberry Fields REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $155.0 million, up 32.4% from fiscal 2024.
- Revenue
- +0.70%
- EPS
- −262.5%
- Free cash flow
- +129.5%
Quarter to September 2026, against a year earlier
12.44
0.01
+0.08%
Follow STRW
Alert me
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 6 | 7 | 7 |
P/E ratio |
6.70 | 3.13 | 19.74 | 18.49 | 21.48 |
P/S ratio |
0.54 | 0.55 | 0.49 | 0.64 | 1.07 |
P/FCF ratio |
1.54 | 1.02 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
2.84 | 3.80 | 3.79 | 3.03 | 8.09 |
P/B ratio |
1.08 | 1.04 | 1.04 | 0.90 | 3.29 |
Price to Tangible BV |
1.43 | 1.36 | 1.27 | 1.35 | 0.00 |
EV/Sales |
0.15 | 0.06 | 0.11 | (0.16) | 0.64 |
EV/EBITDA |
0.22 | 0.07 | 0.14 | 0.00 | 0.74 |
EV/Operating CF |
0.41 | 0.11 | 0.20 | (0.31) | 1.11 |
EV/FCF |
0.41 | 0.11 | (0.21) | 0.34 | (4.98) |
Quick Ratio |
0.23 | 0.18 | 0.13 | 6.48 | 1.56 |
Current Ratio |
0.26 | 0.22 | 0.17 | 7.37 | 1.88 |
Net Debt/EBITDA |
(0.79) | (0.57) | (0.48) | (0.97) | (0.50) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.17 | 0.17 | 0.17 | 0.19 |
Operating CF/Net income |
113.96 | 27.50 | 22.01 | 14.49 | 11.89 |
Capex/Depreciation |
(2.20) | (0.02) | (3.53) | (3.21) | (2.20) |
Interest Coverage |
1.57 | 2.20 | 1.78 | 1.76 | 1.65 |
| 0.00% | 4.39% | 5.16% | 6.26% | 11.30% | |
| 0.00% | 0.33% | 0.43% | 0.58% | 0.91% | |
ROIC |
0.00% | 848.27% | 311.61% | 0.00% | 0.00% |
Return on Tangible Assets |
0.18% | 1.39% | 1.73% | 0.56% | 1.02% |
Average Days of Receivables |
97.56 | 92.82 | 85.34 | 86.38 | 81.96 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
7.24% | 6.50% | 5.67% | 5.85% | 5.55% |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.01 | 0.04 | 0.08 |
Share Based Compensation of Revenue |
0.29% | 0.00% | 0.00% | 0.00% | 1.09% |
Graham Net Nets |
(7.09) | (7.97) | (10.01) | (7.54) | (4.28) |
Graham Number |
0.00 | 22.48 | 8.07 | 12.27 | 7.39 |
Earnings Yield |
14.92% | 32.00% | 5.06% | 5.41% | 4.66% |
Free Cash Flow Yield |
64.78% | 98.24% | (108.38%) | (72.67%) | (12.02%) |
Revenue per Share |
14.89 | 15.40 | 15.68 | 16.43 | 12.21 |
Operating CF per Share |
7.66 | 8.48 | 8.63 | 8.33 | 7.09 |
Capex per Share |
(10.95) | (0.09) | (16.98) | (15.99) | (8.67) |
Free Cash Flow per Share |
(3.29) | 8.39 | (8.35) | (7.66) | (1.58) |
Cash per Share |
8.92 | 7.61 | 5.93 | 13.15 | 5.26 |
Shareholders Equity per Share |
6.00 | 8.22 | 7.43 | 11.73 | 3.98 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.00 | 8.22 | 7.43 | 11.73 | 3.98 |
Free Cash Flow |
(19.24) | 50.41 | (53.12) | (54.57) | (20.00) |
Working Capital |
(244.68) | (306.07) | (374.30) | 119.23 | 57.39 |
Capital Expenditures |
(64.02) | (0.51) | (108.06) | (113.90) | (110.04) |
Net Current Asset Value |
(449.69) | (408.96) | (490.72) | (566.07) | (712.32) |
EV/EBIT |
0.31 | 0.11 | 0.24 | 0.00 | 1.18 |
Capex to Sales |
0.74 | 0.01 | 1.08 | 0.97 | 0.71 |
Price to Operating Income |
1.16 | 1.03 | 1.03 | 1.22 | 1.97 |
| Other line items | |||||
Depreciation/Fixed assets |
0.06 | 0.07 | 0.06 | 0.06 | 0.07 |
Cash ROIC |
(22.07%) | 53.02% | (62.47%) | (30.79%) | (17.05%) |
Accounts Receivable Turnover |
0.00 | 3.96 | 4.26 | 4.59 | 4.96 |
Accounts Payable Turnover |
0.00 | 0.79 | 0.98 | 0.85 | 0.77 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
663.74 | 366.60 | 410.91 | 449.01 | 514.93 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 23.40 | 23.43 | 25.52 | 31.25 |
Average Payables |
— | 17.19 | 15.32 | 17.81 | 20.54 |
Average Assets |
— | 558.48 | 581.90 | 702.19 | 836.41 |
Average Common Equity |
— | 42.22 | 48.33 | 65.42 | 67.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026